Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm, vol.2, p.62, 2015. ,
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease, Mult Scler, vol.21, issue.7, pp.866-74, 2015. ,
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.6, p.163, 2015. ,
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, Lancet, vol.364, issue.9451, pp.2106-2118, 2004. ,
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study, PLoS ONE, vol.10, issue.7, p.127757, 2015. ,
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and longterm outcome, J Neuroinflammation, vol.13, issue.1, p.280, 2016. ,
Long-term follow-up of neuromyelitis optica with a pediatric onset, Neurology, vol.75, issue.12, pp.1084-1092, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00617751
MOG antibody-associated diseases, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.1, p.60, 2015. ,
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients, J Neuroinflammation, vol.9, p.14, 2012. ,
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain, Acta Neuropathol Commun, vol.2, p.35, 2014. ,
Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor ?1 subunit in patients with isolated optic neuritis, JAMA Neurol, vol.72, issue.2, pp.187-93, 2015. ,
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, Brain, vol.125, pp.1450-61, 2002. ,
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders, J Neuroinflammation, vol.8, p.184, 2011. ,
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement -frequency, presentation and outcome, J Neuroinflammation, vol.13, issue.1, p.281, 2016. ,
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography, Mult Scler, vol.21, issue.6, pp.678-88, 2015. ,
Neuromyelitis optica: clinical features, immunopathogenesis and treatment, Clin Exp Immunol, vol.176, issue.2, pp.149-64, 2014. ,
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.4, p.131, 2015. ,
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis, Neurol Neuroimmunol Neuroinflamm, vol.1, issue.4, p.40, 2014. ,
Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders, Mult Scler Relat Disord, vol.11, pp.45-50, 2017. ,
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders, JAMA Neurol, vol.72, issue.1, pp.81-88, 2015. ,
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, vol.85, issue.2, pp.177-89, 2015. ,
The spectrum of neuromyelitis optica, Lancet Neurol, vol.6, issue.9, pp.805-820, 2007. ,
Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature, Brain Pathol, vol.23, issue.6, pp.661-83, 2013. ,
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study, J Neurol Neurosurg Psychiatr, vol.87, issue.4, pp.446-454, 2016. ,
Neuromyelitis Spectrum Disorders, Mayo Clin Proc, vol.92, issue.4, pp.663-79, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02065598
IgG marker of opticspinal multiple sclerosis binds to the aquaporin-4 water channel, J Exp Med, vol.202, issue.4, pp.473-480, 2005. ,
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica, Neurology, vol.80, issue.15, pp.1406-1420, 2009. ,
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin, J Neuroinflammation, vol.13, issue.1, p.279, 2016. ,
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, vol.14, issue.2, pp.177-89, 2015. ,
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis, PLoS ONE, vol.8, issue.6, p.66151, 2013. ,
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies, Neurology, vol.73, issue.4, pp.302-310, 2009. ,
Acute optic neuritis: Unmet clinical needs and model for new therapies, Neurol Neuroimmunol Neuroinflamm, vol.2, issue.4, p.135, 2015. ,
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS), J Neurol, vol.261, issue.1, pp.1-16, 2014. ,
Determinants of Normal Retinal Nerve Fiber Layer Thickness Measured by Stratus OCT, Ophthalmology, 2007. ,
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, Neurology, vol.82, issue.6, pp.474-81, 2014. ,
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgGseropositive versus AQP4-IgG-seropositive patients, J Neuroinflammation, vol.13, issue.1, p.282, 2016. ,
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody, Mult Scler, 2015. ,
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelinoligodendrocyte glycoprotein antibodies: a comparative study, JAMA Neurol, vol.71, issue.3, pp.276-83, 2014. ,
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome, J Neuroinflammation, vol.13, issue.1, p.280, 2016. ,
Longterm follow-up of neuromyelitis optica with a pediatric onset, Neurology, vol.75, issue.12, pp.1084-1092, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00617751